×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)

Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)

货号:CL-0102

规格:1×10⁶cells/T25培养瓶

价格: ¥1600

生长培养基:MEM(含NEAA)10% FBS1% P/S

数量: - +

  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
  • Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确) ¥1600
Hep 3B2.1-7细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1950¥2050

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 Hep 3B2.1-7 (人肝癌细胞) (STR鉴定正确)
别称 Hep 3B2_1-7; Hep 3B2; HEP-3B2; HEP3B2; Hep-3B; HEP-3B; Hep 3B; Hep3B; HEP3B
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:3
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 Hep 3B2.1-7细胞是来自8岁男性黑人的组织。Hep 3B2.1-7细胞的染色体模式数目为60,在裸鼠中能致瘤。Hep 3B2.1-7细胞整合了完整的乙型肝炎病毒基因组,需在2级生物安全防护下操作。
年龄(性别) 男性;8岁
组织来源 肝细胞癌,肝
细胞类型 肿瘤细胞
肿瘤类型 肝胆癌细胞
生物安全等级 BSL-2
倍增时间 ~40-50 hours
致瘤性 Yes, in nude mice.
基因表达情况 alpha fetoprotein (alpha-fetoprotein); hepatitis B surface antigen (HBsAg); albumin; alpha2 macroglobulin (alpha-2-macroglobulin); alpha1 antitrypsin (alpha-1-antitrypsin); transferrin;, alpha1 antichymotrypsin (alpha-1-antichymotrypsin); haptoglobin; ceruloplasmin; plasminogen; complement (C3, C4); C3 activator; fibrinogen; alpha1 acid glycoprotein (alpha-1 acid glycoprotein);, alpha2 HS glycoprotein (alpha-2-HS-glycoprotein); beta lipoprotein (beta-lipoprotein); retinol binding protein (retinol-
保藏机构 ATCC; HB-8064 BCRC; 60434 BCRJ; 0357 DSMZ; ACC-93 ECACC; 86062703
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 8
    D2S1338 21,25
    D3S1358 15
    D5S818 13
    D7S820 8,10
    D8S1179 12
    D13S317 12,14
    D16S539 10
    D18S51 20
    D19S433 12.2,14
    D21S11 30,31
    FGA 18
    PentaD 12,14
    PentaE 5,16
    TH01 6,7
    TPOX 9
    vWA 17
    D6S1043 12,17
    D12S391 17
    D2S441 10,12
  • STR鉴定图
参考文献
文献列表
  • SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma(2022/11/15)

    作者:Hu, Qingqing, Liu, Qiuhong, Zhao, Yalei, Zhang, Lingjian, Li, Lanjuan

    期刊:Biomarker Research

    DOI:10.1186/s40364-022-00422-z

    影响因子 :11.100

    引用产品:CL-0102 CL-0212

  • The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP(2023/10/12)

    作者:Zelin Tian, Chen Xu, Weixiang He

    期刊:CANCER LETTERS

    DOI:10.1016/j.canlet.2023.216439

    影响因子 :9.700

    引用产品:CL-0102

  • ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression(2022/08/01)

    作者:Yu You, Diguang Wen, Lu Zeng

    期刊:International Journal of Biological Sciences

    DOI:10.7150/ijbs.70149

    影响因子 :9.200

    引用产品:CL-0102 CL-0103 CL-0120 CL-0212 CL-0233 CL-0341

  • S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway(2022/08/16)

    作者:Yan Sun, Huan Zhang, Junpeng Meng

    期刊:Cell Reports

    DOI:10.1016/j.celrep.2022.111194

    影响因子 :8.800

    引用产品:CL-0005 CL-0102 CL-0103 CL-0120 CL-0212

  • LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway(2021/11/27)

    作者:Ying Xing,Yang Liu,Zhong Qi

    期刊:Cellular & Molecular Biology Letters

    DOI:10.1186/s11658-021-00295-4

    影响因子 :8.300

    引用产品:CL-0102 CL-0120 CL-0212

  • 5′-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I(2023/03/28)

    作者:Chengdong Wu, Dekai Liu, Lufei Zhang

    期刊:Frontiers of Medicine

    DOI:10.1007/s11684-022-0966-6

    影响因子 :8.100

    引用产品:CL-0102 CL-0120 CL-0139 CL-0212

  • Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression(2022/01/12)

    作者:Tingting Zou, Yang Wang, Ling Dong

    期刊:CELLULAR AND MOLECULAR LIFE SCIENCES

    DOI:10.1007/s00018-021-04118-9

    影响因子 :8.000

    引用产品:CL-0102

  • USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis(2018/03/02)

    作者:Ling Dong, Le Yu, Chunrong Bai

    期刊:Oncogene

    DOI:10.1038/s41388-018-0137-z

    影响因子 :8.000

    引用产品:CL-0102

  • JMJD6–BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells(2023/10/25)

    作者:Ruifeng Pei, Le Zhao, Yiren Ding

    期刊:Journal of Translational Medicine

    DOI:10.1186/s12967-023-04394-y

    影响因子 :7.400

    引用产品:CL-0102

  • Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT/Raf-1-dependent pathway in hepatocellular carcinoma(2023/04/28)

    作者:Jian Yang, Senlin Li, Jialuo He

    期刊:Cell Death Discovery

    DOI:10.1038/s41420-023-01405-1

    影响因子 :7.000

    引用产品:CL-0102 CL-0103 CL-0212

  • VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4(2022/10/14)

    作者:Xiaobao Shi, Pengfei Zhao, Gang Zhao

    期刊:Cancer Gene Therapy

    DOI:10.1038/s41417-022-00540-8

    影响因子 :6.400

    引用产品:CL-0102 CL-0120 CL-0212 CL-0415

  • An NAD+ -Dependent Deacetylase SIRT7 Promotes HCC Development Through Deacetylation of USP39(2020/07/09)

    作者:Ling Dong, Le Yu, Hui Li

    期刊:iScience

    DOI:10.1016/j.isci.2020.101351

    影响因子 :5.800

    引用产品:CL-0102

  • CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway(2024/01/09)

    作者:Zhengchen Jiang, Bowen Shi, Yun Zhang

    期刊:iScience

    DOI:10.1016/j.isci.2024.108843

    影响因子 :5.800

    引用产品:CL-0102

  • Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients(2022/06/06)

    作者:Xianbin Wu, Zhejun Deng, Xiaomin Liao 

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2022.865917

    影响因子 :5.738

    引用产品:CL-0102 CL-0120

  • BMP9-ID1 Pathway Attenuates N6-Methyladenosine Levels of CyclinD1 to Promote Cell Proliferation in Hepatocellular Carcinoma(2024/01/12)

    作者:Han Chen, Mingming Zhang, Jianhao Li

    期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

    DOI:10.3390/ijms25020981

    影响因子 :5.600

    引用产品:CL-0102

  • Lack of MOF Decreases Susceptibility to Hypoxia and Promotes Multidrug Resistance in Hepatocellular Carcinoma via HIF-1α(2021/09/01)

    作者:Meng Wang, Haoyu Liu, Xu Zhang

    期刊:Frontiers in Cell and Developmental Biology

    DOI:10.3389/fcell.2021.718707

    影响因子 :5.500

    引用产品:CL-0102 CL-0120

  • The bioactive ingredients in Actinidia chinensis Planch. Inhibit liver cancer by inducing apoptosis(2021/08/21)

    作者:Zongchao Hong, Yi Lu, Chongwang Ran

    期刊:Journal Of Ethnopharmacology

    DOI:10.1016/j.jep.2021.114553

    影响因子 :5.400

    引用产品:CL-0102 CL-0120

  • Upregulation of FAM134B inhibits endoplasmic reticulum stress-related degradation protein expression and promotes hepatocellular carcinogenesis(2023/09/20)

    作者:Houhong Wang, Lu Liu, Huihui Gong

    期刊:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

    DOI:10.1111/jcmm.17964

    影响因子 :5.300

    引用产品:CL-0102 CL-0120

  • Asymmetric total synthesis and anti-hepatocellular carcinoma profile of enantiopure euphopilolide and jolkinolide E(2023/06/22)

    作者:Xin Li, Jian Chen, Kaixuan Luo

    期刊:BIOORGANIC CHEMISTRY

    DOI:10.1016/j.bioorg.2023.106688

    影响因子 :5.100

    引用产品:CL-0102 CL-0120

  • Chaetocochin J exhibits anti-hepatocellular carcinoma effect independent of hypoxia(2023/06/25)

    作者:Ping Hu, Linzhen Hu, Yizhan Chen

    期刊:BIOORGANIC CHEMISTRY

    DOI:10.1016/j.bioorg.2023.106701

    影响因子 :5.100

    引用产品:CL-0102 CL-0103

  • Identification and Characterization of Cell Lines HepG2, Hep3B217 and SNU387 as Models for Porcine Epidemic Diarrhea Coronavirus Infection(2022/12/10)

    作者:Lilei Lv, Huaye Luo, Lingxue Yu

    期刊:Viruses-Basel

    DOI:10.3390/v14122754

    影响因子 :4.700

    引用产品:CL-0034 CL-0102 CL-0103 CL-0120 CL-0139

  • Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration in vitro.(2022/11/11)

    作者:Yuan Guo, Hong Tao Hu, Shi Jun Xu, Wei Li Xia, Yan Zhao, Xiao Hui Zhao, Wen Bo Zhu, Fang Ting Li, Hai Liang Li

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2022.1023801

    影响因子 :4.700

    引用产品:CL-0005 CL-0102

  • Circ_0007429/miR-637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC(2023/03/15)

    作者:Lilan Fan, Panpan Xia, Jing Wang

    期刊:MOLECULAR CARCINOGENESIS

    DOI:10.1002/mc.23526

    影响因子 :4.600

    引用产品:CL-0102 CL-0103 CL-0120 CL-0212

  • Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression(2023/12/04)

    作者:Yikai Wang, Muqi Wang, Chenrui Liu

    期刊:Scientific Reports

    DOI:10.1038/s41598-023-48812-z

    影响因子 :4.600

    引用产品:CL-0102

  • Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways(2021/02/09)

    作者:Liang Yu, Meng Wang, Yang Yang

    期刊:Plos Computational Biology

    DOI:10.1371/journal.pcbi.1008696

    影响因子 :4.300

    引用产品:CL-0102 CL-0103 CL-0277

  • ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway(2021/06/07)

    作者:Jianwen Liu, Ruiqing Liu, Yuyan Liu

    期刊:Cell Cycle

    DOI:10.1080/15384101.2021.1919828

    影响因子 :4.300

    引用产品:CL-0102 CL-0120

  • LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis(2020/09/16)

    作者:Ganghua Yang, Lijing Zhou, Qinhong Xu

    期刊:Cell Cycle

    DOI:10.1080/15384101.2020.1809259

    影响因子 :4.300

    引用产品:CL-0102 CL-0119 CL-0212

  • LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p(2023/06/07)

    作者:Lu Li, Rong Ai, Xiwei Yuan

    期刊:Journal of Hepatocellular Carcinoma

    DOI:10.2147/JHC.S410891

    影响因子 :4.100

    引用产品:CL-0102 CL-0120 CL-0560

  • Circular RNA circBNC2 facilitates glycolysis and stemness of hepatocellular carcinoma through the miR-217/high mobility group AT-hook 2 (HMGA2) axis.(2023/06/09)

    作者:Yan Feng, Shufeng Xia, Junlan Hui

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2023.e17120

    影响因子 :4.000

    引用产品:CL-0102 CL-0120

  • Long noncoding RNA HULC regulates the NF-κB pathway and represents a promising prognostic biomarker in liver cancer(2022/10/10)

    作者:Shihai Liu, Lakshmi Huttad, Guifang He

    期刊:Cancer Medicine

    DOI:10.1002/cam4.5263

    影响因子 :4.000

    引用产品:CL-0102 CL-0103 CL-0120 CL-0560

  • The abrogation of GRP78 sensitizes liver cancer cells to lysionotin by enhancing ER stress-mediated pro-apoptotic pathway(2023/06/16)

    作者:Ying Zou, Hewen Shi, Haiyan Lin

    期刊:CELL STRESS & CHAPERONES

    DOI:10.1007/s12192-023-01358-5

    影响因子 :3.800

    引用产品:CL-0102 CL-0103

  • HuR-induced circ_0082319 contributes to hepatocellular carcinoma by elevating PTK2 through miR-505-3p(2023/10/25)

    作者:Chuntang Qin, Shuyan Liu, Weibin Chen

    期刊:NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

    DOI:10.1007/s00210-023-02793-y

    影响因子 :3.600

    引用产品:CL-0102

  • Active compounds and potential targets of Shuganning injection in the treatment of hepatocellular carcinoma by network pharmacology and in vitro validation(2023/03/04)

    作者:Xiao Han, Jiayan Huang, Jia Lu

    期刊:NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

    DOI:10.1007/s00210-023-02432-6

    影响因子 :3.600

    引用产品:CL-0102 CL-0120

  • LncRNA FAM13A-AS1, transcriptionally regulated by PHOX2B, modulates hepatocellular carcinoma chemoresistance via stabilizing PPARγ(2023/06/16)

    作者:Daowen Ye, Jun Ma, Tingdong Yu

    期刊:GENE

    DOI:10.1016/j.gene.2023.147570

    影响因子 :3.500

    引用产品:CL-0102 CL-0103 CL-0120

  • Transcriptome-Wide Dynamics of m7G-Related LncRNAs during the Progression from HBV Infection to Hepatocellular Carcinoma(2023/12/19)

    作者:Min Shi, Shunshun Zhu, Linying Sun

    期刊:Frontiers in Bioscience-Landmark

    DOI:10.31083/j.fbl2812339

    影响因子 :3.100

    引用产品:CL-0102

  • Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis(2021/1/12)

    作者:Lili Zhao, Ning Ma, Gaihong Liu

    期刊:Digestive Diseases And Sciences

    DOI:10.1007/s10620-020-06787-1

    影响因子 :3.100

    引用产品:CL-0102 CL-0120

  • NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma(2023/01/21)

    作者:Zigang Li, Chengshan You, Jun Huang

    期刊:MEDICAL SCIENCE MONITOR

    DOI:10.12659/MSM.938410

    影响因子 :3.100

    引用产品:CL-0102 CL-0212

  • Matrine inhibits cell proliferation, invasion, and stem cell formation in hepatocellular carcinoma by regulating the ELAVL1/RBM3-mediated Wnt/β-catenin signaling pathway(2024/01/23)

    作者:Chunhua Song, Hongwei Li, Zhengchun Huang

    期刊:Chemical Biology & Drug Design

    DOI:10.1111/cbdd.14442

    影响因子 :3.000

    引用产品:CL-0102

  • Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancer(2023/08/30)

    作者:Junying Wang, Guangyu Zhu

    期刊:Oncology Letters

    DOI:10.3892/ol.2023.14034

    影响因子 :2.900

    引用产品:CL-0102 CL-0103 CL-0120 CL-0139 CL-0415 PB180120 PM150110 PM150210

  • Role of SLC39A6 in the development and progression of liver cancer(2022/01/11)

    作者:Zhen Wan, Xuzhen Wang

    期刊:Oncology Letters

    DOI:10.3892/ol.2022.13197

    影响因子 :2.900

    引用产品:CL-0102 CL-0103

  • CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway(2021/07/14)

    作者:Xitao Liu, Defang Zhao

    期刊:Animal Cells and Systems

    DOI:10.1080/19768354.2021.1953142

    影响因子 :2.900

    引用产品:CL-0102 CL-0120

  • Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3(2023/06/16)

    作者:Zongqiang Hu, Yingpeng Zhao, Laibang Li

    期刊:MOLECULAR BIOLOGY REPORTS

    DOI:10.1007/s11033-023-08492-4

    影响因子 :2.800

    引用产品:CL-0102 CL-0120

  • Activation of YAP1 by STK25 contributes to the progression of hepatocellular carcinoma(2022/04/06)

    作者:Jiong Jiang, Ying Zheng, Fenrong Chen

    期刊:TISSUE & CELL

    DOI:10.1016/j.tice.2022.101797

    影响因子 :2.600

    引用产品:CL-0102

  • Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p(2021/11/19)

    作者:Lan Gao, Xiufeng Zhang

    期刊:Tissue & Cell

    DOI:10.1016/j.tice.2021.101680

    影响因子 :2.600

    引用产品:CL-0102 CL-0120 CM-0102 CM-0120

  • Polygonatum sibiricum Polysaccharide Inhibited Liver Cancer in a Simulated Tumor Microenvironment by Eliminating TLR4/STAT3 Pathway(2023/09/01)

    作者:Yunke Xu, Yong Guo, Changyou Lu

    期刊:BIOLOGICAL & PHARMACEUTICAL BULLETIN

    DOI:10.1248/bpb.b23-00198

    影响因子 :2.000

    引用产品:CL-0102 CL-0103 CP-H187B

  • Inhibitory Effect of Hernandezine on the Proliferation of Hepatocellular Carcinoma(2023/02/01)

    作者:Chiufai Kuok, Qi Wang, Pedro Fong

    期刊:BIOLOGICAL & PHARMACEUTICAL BULLETIN

    DOI:10.1248/bpb.b22-00612

    影响因子 :2.000

    引用产品:CL-0102 CL-0103

  • 点击展开收起列表
丁莎/胡文君

丁莎/胡文君

【 上海 】

凌晶

凌晶

【 陕西 】

朱莎莉

朱莎莉

【 湖北、河南 】

刘本佳

刘本佳

【 江苏、安徽 】

章臣雄

章臣雄

【 广东、云南 】

閤春喜

閤春喜

【 四川、甘肃、西藏 】

田博浩

田博浩

【 重庆、吉林 】

石文平

石文平

【 北京、黑龙江、辽宁 】

任施博

任施博

【 江西、福建、新疆、海南 】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 湖南、山东、宁夏、青海 】

尹国文

尹国文

【浙江、广西、贵州】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询
联系销售

关注微信公众号